Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about Tgf-Β: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Tgf-Β is a biological pathway involved in neurodegeneration research. Key relationships include: activates, therapeutic target, inhibits. Associated with ALS, Aging, Als. Connected to 691 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | Tgf-Β |
| Key Genes/Proteins | ABCB1, ABCG2, ACSL4, ACSL5, ACVR2A, adamts4 |
| Related Diseases | aging, Aging |
| Related Pathways | Akt |
graph TD
Tgf__["Tgf-Beta"] -->|"interacts"| Circadian_Rhythm["Circadian Rhythm"]
Tgf__["Tgf-Beta"] -->|"interacts"| Mapk["Mapk"]
Tgf__["Tgf-Beta"] -->|"interacts"| Apoptosis["Apoptosis"]
Tgf__["Tgf-Beta"] -->|"interacts"| Ferroptosis["Ferroptosis"]
Tgf__["Tgf-Beta"] -->|"interacts"| Immune_Response["Immune Response"]
Tgf__["Tgf-Beta"] -->|"interacts"| Innate_Immunity["Innate Immunity"]
MIRO1["MIRO1"] -->|"associated"| Tgf__["Tgf-Beta"]
APP["APP"] -->|"therapeutic target"| Tgf__["Tgf-Beta"]
ST6GAL1["ST6GAL1"] -->|"regulates"| Tgf__["Tgf-Beta"]
MAX["MAX"] -->|"regulates"| Tgf__["Tgf-Beta"]
style Tgf__ fill:#1b5e20,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| MICROGLIA | activates | cell_type | 0.90 |
| Neuroinflammation | suppresses | process | 0.80 |
| Exosomes | associated_with | entity | 0.80 |
| Renal Fibrosis | causes | disease | 0.80 |
| MMT | associated_with | process | 0.80 |
| Inflammation | modulates | process | 0.80 |
| Wound healing | associated_with | process | 0.80 |
| M2 anti-inflammatory phenotype | biomarker_for | cell_type | 0.70 |
| GBM | associated_with | disease | 0.70 |
| glioblastoma multiforme | regulates | disease | 0.70 |
| microglial TREM2 activation | modulates | mechanism | 0.70 |
| MMP9 | activates | protein | 0.70 |
| Mtor | interacts_with | pathway | 0.55 |
| Innate Immunity | interacts_with | pathway | 0.55 |
| Immune Response | interacts_with | pathway | 0.55 |
| Circadian Rhythm | interacts_with | pathway | 0.55 |
| Apoptosis | interacts_with | pathway | 0.55 |
| Ferroptosis | interacts_with | pathway | 0.55 |
| Nf-Κb | interacts_with | pathway | 0.55 |
| Insulin Signaling | interacts_with | pathway | 0.55 |
| Mapk | interacts_with | pathway | 0.55 |
| COLORECTAL CANCER | inhibits | disease | 0.50 |
| HEPATOCELLULAR CARCINOMA | inhibits | disease | 0.50 |
| Tgf-Β Signaling | inhibits | pathway | 0.50 |
| BAMBI | regulates | concept | 0.50 |
| Pi3K/Akt | causes | pathway | 0.50 |
| Invasion | causes | pathway | 0.50 |
| PI3K/AKT/mTOR | causes | pathway | 0.50 |
| PD-L1 | activates | concept | 0.50 |
| TGFB | activates | gene | 0.50 |
| Neurodegenerative Diseases | activates | disease | 0.50 |
| ALZHEIMER'S | activates | concept | 0.50 |
| Neuron | regulates | cell_type | 0.50 |
| NEURONS | regulates | concept | 0.50 |
| Stem Cell | activates | cell_type | 0.50 |
| ENDOTHELIAL | activates | concept | 0.50 |
| STEM CELLS | activates | concept | 0.50 |
| ERBB3 | associated_with | concept | 0.50 |
| Epithelial-Mesenchymal Transition | associated_with | process | 0.50 |
| Proteins | associated_with | protein | 0.50 |
| INSULIN | regulates | concept | 0.50 |
| IGF-1 | regulates | concept | 0.50 |
| RAPAMYCIN | regulates | concept | 0.50 |
| Macrophage | activates | cell_type | 0.50 |
| ANGPT1 | activates | concept | 0.50 |
| ANGPT1 | inhibits | concept | 0.50 |
| Invasion | inhibits | pathway | 0.50 |
| MACROPHAGES | activates | concept | 0.50 |
| disease | associated_with | disease | 0.50 |
| Heart Failure | associated_with | disease | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Inflammation | activates | disease | 1.00 |
| Cancer | activates | disease | 1.00 |
| Inflammation | regulates | disease | 1.00 |
| TNF | activates | gene | 1.00 |
| CANCER | activates | gene | 1.00 |
| Tumor | activates | disease | 1.00 |
| Als | therapeutic_target | disease | 1.00 |
| CYTOKINES | activates | gene | 1.00 |
| INFLAMMATION | inhibits | gene | 1.00 |
| Inflammation | inhibits | disease | 1.00 |
| INFLAMMATION | regulates | gene | 1.00 |
| Als | activates | disease | 1.00 |
| TNF-Α | activates | gene | 1.00 |
| AKT | associated_with | gene | 1.00 |
| PI3K | associated_with | gene | 1.00 |
| Tumor | inhibits | disease | 1.00 |
| INFLAMMATION | therapeutic_target | gene | 1.00 |
| AKT | activates | gene | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| Cancer | therapeutic_target | disease | 1.00 |
| AUTOPHAGY | activates | gene | 1.00 |
| PI3K | inhibits | gene | 1.00 |
| Fibrosis | regulates | disease | 1.00 |
| AKT | inhibits | gene | 1.00 |
| Inflammation | therapeutic_target | disease | 1.00 |
| MTOR | activates | gene | 1.00 |
| IL-6 | activates | gene | 1.00 |
| Autoimmune | therapeutic_target | disease | 0.90 |
| NEUROINFLAMMATION | activates | gene | 0.90 |
| Tumor | therapeutic_target | disease | 0.90 |
| Fibrosis | inhibits | disease | 0.90 |
| Fibrosis | therapeutic_target | disease | 0.90 |
| CYTOKINES | inhibits | gene | 0.90 |
| Als | associated_with | disease | 0.90 |
| MIRNAS | regulates | gene | 0.90 |
| Neurodegeneration | therapeutic_target | disease | 0.90 |
| CANCER | therapeutic_target | gene | 0.90 |
| APOPTOSIS | activates | gene | 0.90 |
| Fibrosis | activates | disease | 0.90 |
| ROS | inhibits | gene | 0.90 |
| OXIDATIVE STRESS | inhibits | gene | 0.90 |
| Neuroinflammation | activates | disease | 0.90 |
| Carcinoma | activates | disease | 0.90 |
| Britannin | downregulates | compound | 0.85 |
| Wnt | interacts_with | pathway | 0.80 |
| MTOR | associated_with | gene | 0.80 |
| Cancer | inhibits | disease | 0.80 |
| MTOR | regulates | gene | 0.80 |
| APOPTOSIS | associated_with | gene | 0.80 |
| PI3K | activates | gene | 0.80 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| TGF-β1–SMAD2/3 Axis as Master Suppressor of Microglial Train | 0.712 | neuroinflammation | What specific astrocyte-derived factors |
| TGF-β1-SMAD Signaling Dysregulation | 0.380 | neurodegeneration | Which specific factors in conditioned me |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.861
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 6 · Score: 0.95 · 2026-04-27
closed · Rounds: 4 · Score: 0.50 · 2026-04-27
closed · Rounds: 4 · Score: 0.64 · 2026-04-26
closed · Rounds: 4 · Score: 0.50 · 2026-04-26
closed · Rounds: 4 · Score: 0.92 · 2026-04-26
Hypotheses and analyses mentioning Tgf-Β in their description or question text
No additional research found